Introduction: Epilepsy is a chronic neurological disorder characterized by recurrent seizures. Pharmacological studies indicate that oxidative stress (OS) and reactive oxygen species (ROS) contribute to the pathogenesis of this condition. Natural flavonoids have demonstrated neuroprotective properties. Despite the known medicinal value of Alstonia scholaris, it has been used in various diseases. This study aims to isolate, characterize, and evaluate the antiepileptic activity of quercetin from A. scholaris by ameliorating oxidative stress and antioxidant mechanisms. Material and Methods: Quercetin was isolated using chromatographic techniques and characterized using spectroscopic techniques. Its antiepileptic efficacy and effects of quercetin on oxidative stress and antioxidant markers were assessed in PTZ- and PTX-induced convulsion models. Result: From chromatographic isolation and purification, quercetin was found to be 15mg. Toxicity testing confirmed quercetin's safety up to 2000 mg/kg, p.o., in Wistar albino rats. In the PTZ and PTX models, quercetin at 100 and 400 mg/kg, p.o., possessed a dose-dependent effect on latency and duration of convulsions compared to the vehicle control group. In the PTZ model, quercetin at 100 and 400 mg/kg, p.o., produced 66.67% and 100% mortality protection, respectively. In the PTX models, quercetin at 100 and 400 mg/kg, p.o., produced 50.00% and 83.34% mortality protection, respectively. In biochemical analysis, in the PTZ model, quercetin at 100 and 400 mg/kg, p.o., decreased the MDA level (**p <0.01 and ***p <0.001) and increased the SOD level (**p <0.01 and ***p <0.001). However, in the PTX model, quercetin at 100 and 400 mg/kg, p.o., decreased the MDA level (*p <0.05 and p < 0.001) and increased the SOD level (*p <0.05 and ***p <0.001) in a dose-dependent manner. Discussion: The isolated quercetin from A. scholaris showed potential antiepileptic activity by reducing oxidative stress and enhancing the antioxidant defence mechanism. It decreased the MDA level and enhanced the SOD level in the brain in a dose-dependent manner. Conclusion: The findings support the potential of quercetin as a natural therapeutic candidate for the future treatment of epilepsy.